Neurology – Page 7

Sodium Benzoate as a Promising Treatment for Amnestic Mild Cognitive Impairment: Evidence from a Randomized Controlled Trial

By MedXY 08/27/2025

A 24-week randomized, double-blind trial shows sodium benzoate, a D-amino acid oxidase inhibitor, improves short-term memory in patients with amnestic mild cognitive impairment, suggesting a potential therapeutic role with a favorable safety profile.

Diabetes & Endocrinology Neurology news Specialties

Metabolic Syndrome: The Hidden Highway to Dementia in Older Adults

By MedXY 08/26/2025

Metabolic syndrome—characterized by five key metabolic risk factors—significantly increases the risk of dementia, especially vascular dementia, among older adults. Early detection and lifestyle interventions are crucial to protect brain health.

Family Medicine & Nutrition Neurology news Specialties

13 Brain-Boosting Foods to Help Fight Dementia: Are You Eating These?

By MedXY 08/26/2025

Discover 13 scientifically-supported foods that can help protect and enhance cognitive function, potentially reducing dementia risk as you age.

Neurology Nursing & care Specialties

Acupuncture Enhances Brain White Matter Integrity and Alleviates Postconcussion Symptoms in Mild TBI: Evidence from a Randomized Controlled MRI Study

By MedXY 08/26/2025

This randomized controlled trial demonstrates that acupuncture improves white matter microstructure on MRI and reduces long-term postconcussion symptoms in mild traumatic brain injury patients, with sustained effects at 6-12 months.

Neurology news Psychiatry Specialties

Harnessing Slow-Wave Sleep for Internet Gaming Disorder: Efficacy of Closed-Loop Auditory Exposure

By MedXY 08/26/2025

Closed-loop auditory exposure during slow-wave sleep significantly reduces craving and playtime in Internet Gaming Disorder by modulating sleep spindle power, offering a novel, non-invasive therapeutic strategy.

Diabetes & Endocrinology Gastroenterology Neurology news Specialties

Improving Sleep Quality through Cognitive Behavioural Therapy Alters Food Preferences in Adults with Overweight and Obesity

By MedXY 08/26/2025

Cognitive behavioural therapy for insomnia enhances self-reported sleep quality and duration, reduces cravings for sweet and savoury foods, and shifts implicit food preferences in adults with overweight or obesity, though dietary intake changes remain uncertain.

Clinical Updates Neurology news Specialties

Endovascular Therapy Shows Lasting Benefits Over Medical Management in Large Ischemic Stroke: 1-Year Results from the ANGEL-ASPECT Trial

By MedXY 08/26/2025

The ANGEL-ASPECT trial demonstrates that endovascular therapy (EVT) significantly improves 1-year functional outcomes compared to medical management in patients with large ischemic stroke, confirming durable disability reduction despite similar mortality rates.

Clinical Updates Neurology news Specialties

Nine-Year Outcomes After Lacunar and Mild Cortical Ischemic Stroke: Long-Term Functional, Cognitive, and Vascular Impacts

By MedXY 08/26/2025

This longitudinal study reveals persistent cognitive, physical, and vascular challenges up to 9 years after minor lacunar or cortical ischemic stroke, emphasizing different risks and recovery patterns by stroke subtype.

Family Medicine & Nutrition Medical News Neurology news Specialties

The Science Behind a Cup of Hot Green Tea: Enhancing Memory and Brain Connectivity

By MedXY 08/25/2025

A 12-week clinical trial reveals that heat-treated green tea extract can significantly improve memory and brain network connectivity in middle-aged adults with subjective memory concerns.

Clinical Updates Family Medicine & Nutrition Neurology news Radiology Specialties

Physical Exercise Slows Neurodegeneration and Cognitive Decline in Early Parkinson Disease: Insights from Longitudinal MRI Analysis

By MedXY 08/24/2025

Regular physical activity in early Parkinson disease patients is linked to slower brain atrophy in temporoparietal and limbic regions, mediating better preservation of memory and attention over four years.

AI Clinical Updates Neurology news Pediatrics Specialties

Harnessing Mobile Health to Improve ADHD Symptoms and Executive Functions in Children: A Randomized Controlled Trial of Tailored Exercise Rehabilitation

By MedXY 08/24/2025

A tailored, app-supported exercise program delivered via mobile health significantly improves core ADHD symptoms and executive functions in children, demonstrating comparable effectiveness to traditional face-to-face exercise guidance.

Cardiology Clinical Updates Diabetes & Endocrinology Family Medicine & Nutrition Neurology news Specialties

Recent Advances in Cinnamon and Its Extracts: Clinical Applications and Therapeutic Potentials Across Metabolic, Cardiovascular, Cognitive, and Infectious Diseases

By MedXY 08/24/2025

A decade of research highlights cinnamon's benefits in glycemic control, lipid modulation, anti-inflammatory effects, cognitive enhancement, and antimicrobial activity, supporting its adjunctive clinical use and revealing promising therapeutic directions.

Cardiology Diabetes & Endocrinology Neurology news Specialties

Sulforaphane in Clinical Medicine: A Decade of Research Progress and Therapeutic Potential

By MedXY 08/24/2025

This review synthesizes 10 years of sulforaphane (SFN) research, highlighting its pharmacology, clinical trial outcomes, and emerging therapeutic prospects across cancer, metabolic, renal, neurodevelopmental, and cardiovascular disorders.

Family Medicine & Nutrition Medical News Neurology news Specialties

Stroke Strikes Silently but Is 90% Preventable: Recognize the Warning Signs and Act Fast

By MedXY 08/23/2025

Stroke, a sudden interruption of brain blood flow, can lead to severe disability or death but is largely preventable. Early recognition and timely intervention can save lives and reduce complications.

Neurology Specialties

Apitegromab (SAPPHIRE): phase 3 trial shows modest motor gains in non‑ambulatory type 2/3 spinal muscular atrophy on SMN therapies

By MedXY 08/22/2025

The SAPPHIRE phase 3 trial found that adding apitegromab to nusinersen or risdiplam produced a small but statistically significant improvement in motor function in children aged 2–12, with a safety profile similar to placebo.

Neurology Specialties

Unlocking Dementia Prevention in Brazil: Impact of 14 Modifiable Risk Factors on Reduction Potential

By MedXY 08/22/2025

Nearly 60% of dementia cases in Brazil could be prevented by addressing 14 modifiable risk factors, highlighting a crucial public health opportunity in a middle-income country setting.

Cardiology Neurology Specialties

Unveiling the Impact of Pre-Clinical Alzheimer’s Disease on Blood Pressure: Insights from UK Biobank Mendelian Randomisation Studies

By MedXY 08/21/2025

This study presents compelling evidence that pre-clinical Alzheimer’s disease increases systolic blood pressure, using innovative Mendelian randomisation and parental dementia instruments in UK Biobank data. These findings highlight complex vascular interactions preceding clinical dementia.

Neurology news Pathology & Lab Medicine Specialties

High-sensitivity cardiac troponin I levels are associated with Alzheimer’s disease in women?

By MedXY 08/21/2025

Elevated hs-cTnI levels below myocardial injury thresholds associate with increased late-life dementia risk in older women, highlighting cardiovascular biomarkers’ potential to identify vulnerable individuals for dementia prevention.

Neurology news Specialties

Harnessing Exosomes in Neurodegenerative Diseases: Therapeutic Promise and Modification Techniques

By MedXY 08/20/2025

Exosomes, nanoscale vesicles capable of crossing the blood–brain barrier, hold significant potential as targeted therapeutic agents and diagnostic markers in neurodegenerative diseases. Advances in genetic, chemical, and nanomaterial modifications enhance their targeting, representing a promising frontier for treatment.

Neurology news Specialties

FDA Approves Tonmya: First Nonopioid Sublingual Treatment Targeting Sleep in Fibromyalgia

By MedXY 08/19/2025

The FDA has approved Tonmya (sublingual cyclobenzaprine) as the first new fibromyalgia therapy in 15 years, targeting nonrestorative sleep to alleviate pain, fatigue, and cognitive symptoms in adults.